NCT02118090 arm group 4e242995d6e91ded48a439590419af9d [clinicaltrials_resource:NCT02118090/arm-group/4e242995d6e91ded48a439590419af9d]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02118090 arm group 4e242995d6e91ded48a439590419af9d [clinicaltrials_resource:NCT02118090/arm-group/4e242995d6e91ded48a439590419af9d]
Bio2RDF identifier
NCT02118090/arm-group/4e242995d6e91ded48a439590419af9d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 242995d6e91ded48a439590419af9d
description [clinicaltrials_vocabulary:description]
Patients treat with chloroquine sulfate (NIVAQUINE) 10 mg/kg/day - 3 days
identifier
clinicaltrials_resource:NCT02118090/arm-group/4e242995d6e91ded48a439590419af9d
title
NCT02118090 arm group 4e242995d6e91ded48a439590419af9d
@en
type
label
NCT02118090 arm group 4e242995 ...... 42995d6e91ded48a439590419af9d]
@en